Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists ’ professional practices

ConclusionOncologists were clearly aware of CIPN risks, but its incidence tended to be underestimated and the ASCO recommendations for the management of CIPN were not followed. The prevention, diagnosis and management of CIPN remain problematic in clinical practice in France.Trial registrationClinicalTrials.gov: NCT03854864
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research